Clinical Trial Update: Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for intravenous aviptadil in adults with critical COVID-19 and respiratory failure, including ARDS, with completed status and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical COVID-19 with Respiratory Failure
• Respiratory Distress Syndrome

Drugs mentioned

• Aviptadil (aviptadil)

Snippet

Sponsor: APR Applied Pharma Research s.a. | Conditions: Critical COVID-19 With Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-07-24